I N Hampson
Overview
Explore the profile of I N Hampson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliver A, He X, Borthwick K, Donne A, Hampson L, Hampson I
Br J Cancer
. 2010 Dec;
104(2):324-31.
PMID: 21139582
Background: Guanidine exchange factor (GEF)-catalysed activation of Rho proteins such as Cdc42 has been shown to have a crucial role in cellular transformation, malignant progression and invasion. We have previously...
2.
Donne A, Hampson L, Homer J, Hampson I
Int J Pediatr Otorhinolaryngol
. 2009 Oct;
74(1):7-14.
PMID: 19800138
Objective: Human Papillomavirus (HPV) 6 and 11 are the aetiological agents responsible for Recurrent Respiratory Papillomatosis (RRP). There is general consensus that HPV11 results in more aggressive disease compared to...
3.
Hampson L, He X, Oliver A, Hadfield J, Kemp T, Butler J, et al.
Br J Cancer
. 2009 Aug;
101(5):829-39.
PMID: 19707205
Background: Constitutive activation of RhoA-dependent RhoA kinase (ROCK) signalling is known to promote cellular transformation and the ROCK inhibitor Y-27632 has the ability to suppress focus formation of RhoA transformed...
4.
Hampson L, Hampson I, Babichuk C, Cotter L, Bleackley R, Dexter T, et al.
Hematol J
. 2002 Mar;
2(3):150-60.
PMID: 11920240
Introduction: The serine protease inhibitor Serpin 2A is highly expressed in ex vivo bipotent granulocyte/macrophage progenitor cells and in cultured myeloid stem cells. The gene undergoes rapid down-regulation as these...
5.
Hampson L, El Hady E, Moore J, Kitchener H, Hampson I
FASEB J
. 2001 Jun;
15(8):1445-7.
PMID: 11387252
No abstract available.
6.
Martin-Hirsch P, Stern P, Moore J, Corbitt G, Kitchener H, Hampson I
Cancer Res
. 2001 Feb;
61(1):192-6.
PMID: 11196160
Topical 5-aminolevulinic acid-based photodynamic therapy (PDT) has produced complete response rates of >90% for nonmelanoma skin carcinomas, which are mostly human papillomavirus (HPV) negative. Using a similar treatment protocol, we...
7.
Li C, Hampson I, Hampson L, Kumar P, Bernabeu C, Kumar S
FASEB J
. 2000 Jan;
14(1):55-64.
PMID: 10627280
CD105 (endoglin), a receptor for transforming growth factor beta (TGFbeta), is highly expressed in tissue-cultured, activated endothelial cells in vitro and in tissues undergoing angiogenesis in vivo. The absence of...
8.
Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson I, Shimamoto A, et al.
Genes Dev
. 1999 Dec;
13(22):3027-33.
PMID: 10580009
The p16(INK4a) tumor suppressor inhibits cyclin-dependent kinases (CDK4 and CDK6). Here we report the isolation of a novel gene, SEI-1, whose product (p34(SEI-1)) appears to antagonize the function of p16(INK4a)....
9.
Johnson B, John V, Henschler R, Hampson I, Heyworth C, Babichuk C, et al.
Gene
. 1999 Jul;
234(1):101-7.
PMID: 10393244
Cytotoxic T cells and early haemopoietic progenitors share the expression of a number of specific genes. Of these, granzyme B has attracted particular interest because of its role in inducing...
10.